Talphera announced as part of its commitment to operating with best practices in corporate governance, its Board of Directors has decided to reduce the size of the Board from ten to seven directors. Three directors, Howard Rosen, Richard Afable and Pamela Palmer have voluntarily agreed to resign from the Board of Directors, effective immediately. Dr. Palmer will continue in her current role of Chief Medical Officer and member of the executive leadership team, with a focus on successfully completing the Niyad registrational study later this year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on TLPH:
- Talphera files to sell 7.79M shares of common stock for holders
- Talphera price target raised to $6 from $5 at H.C. Wainwright
- Talphera announces $26M capital commitment
- Xoma expands commercial royalty, milestone portfolio with DSUVIA acquisition
- Talphera Announces $26 Million Capital Commitment Through a Combination of a Non-Dilutive Royalty Monetization and Equity Offering
